메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

ADFW의 핀테크 아부다비, 혁신과 파격으로 새로운 금융 시대 예고

아부다비, 아랍에미리트, 2025년 12월 11일 -- 2025년 아부다비 금융 주간(Abu Dhabi Finance Week, ADFW) 사흘째를 맞아 열린 아부다비 글로벌 마켓(Abu Dhabi Global Market, ADGM)의 대표적인 행사인 핀테크 아부다비(Fintech Abu Dhabi)와 리졸브(RESOLVE)에 세계에서 가장 영향력 있는 금융, 기술, 법률, 분쟁 해결 분야의 수장들이 총집결했다. '자본의 수도 설계(Engineering the Capital of Capital)'라는 대주제 아래 사고 리더십, 파격적 혁신에 대한 토론, 그리고 선도적인 통찰력이 강렬하게 어우러져 진행된 이날 행사는 아부다비가 미래를 선도하는 금융 중심지이자 법률 강국임을 입증하는 자리였다. 아부다비 경제 개발부(Department of Economic Development Abu Dhabi) 차관 겸 ADGM 아카데미(ADGM Academy) 총장 함마드 사야 알 마즈루에이(H.E. Hamad Sayah Al Mazrouei)는 이날 개회사에서 "금융의 미래는 알고리즘만으로 완성할 수 없으며, 비전과 용기,
- 황정호 기자
- 2025-12-11 17:39
DAR GLOBAL 、ドバイのトランプ・インターナショナル・ホテル＆タワーの基盤工事契約をEDRAFOR EMIRATES LLCに授与

ドバイ（UAE）, 2025年12月11日 -- ロンドン上場の高級不動産開発会社であるDar Globalは、ドバイのトランプ・インターナショナル・ホテル＆タワーの基盤工事契約をEdrafor Emirates LLCに授与しました。これによって、ダウンタウン・ドバイ入口のシェイク・ザイード・ロードに位置するこのランドマーク開発の建設推進において重要な節目を迎えました。本年4月に発表されたドバイのトランプ・インターナショナル・ホテル＆タワーは、世界最高峰のホスピタリティ、ラグジュアリー住宅、そして選りすぐられたグローバル居住者コミュニティ向けに設計された会員制プライベートクラブ「The Trump」を融合し、新たな世界的アイコンとなる予定です。80階建てのタワーは高さ350メートルに達し、ドバイ最高峰の屋外プール、ニューヨーク・5番街のトランプタワーに着想を得た超希少ペントハウス2室、ブルジュ・ハリファを一望するパノラマビューを備えます。 Edrafor Emirates LLCは、本格的な建設に向けた用地整備に必要な基盤工事を実施します。その範囲には、地盤改良工事、深層基盤システム、物流動員が含まれ、この規模とラグジュアリー性を備えた開発に求められる最高水準を確保します。 Dar GlobalのCEO、Ziad El
- 황정호 기자
- 2025-12-11 17:27
ATFX Accelerates Real-Time Trading Innovation with KX's AI-Driven Data Platform for Smarter Trading

HONG KONG, Dec. 11, 2025 -- ATFX, a globally regulated fintech broker specialising in FX and CFDs, is proud to announce a strategic data infrastructure collaboration with KX, a leading software company specialising in time-series data management and analytics. This collaboration aims to enhance ATFX's technology platform with faster analytics, smarter automation, and greater operational efficiency, delivering more timely insights and better decision-making across its trading operations. These operations involve managing complex data flows from numerous liquidity providers and prime brokers, s
- 황정호 기자
- 2025-12-11 17:00
Qudian Inc. Announces Name and Ticker Change

XIAMEN, China, Dec. 11, 2025 -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company in China, today announced the change of its name to "High Templar Tech Limited" and its ticker symbol to "HTT". As previously announced by the Company on November 12, 2025, its board of directors (the "Board") resolved to (i) change the Company's name to "High Templar Tech Limited" (the "Name Change"), subject to shareholders' approval to be obtained at an extraordinary general
- 황정호 기자
- 2025-12-11 17:00
Yiren Digital Wins "Technology Innovation Leadership Award for Listed Companies" at the 23rd China's Financial Annual Champion Awards

BEIJING, Dec. 11, 2025 -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading Fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and Southeast Asia, today announced it has been awarded the "Technology Innovation Leadership Award for Listed Companies" at the 23rd China's Financial Annual Champion Awards. The award was presented during the 2025 China Financial Annual Conference, held in Beijing and co-hosted by the China Stock Exchange Executive Council and the leading financ
- 황정호 기자
- 2025-12-11 15:40
2025 Taiwan American Whiskey & Bourbon Festival concludes with Resounding Success

[ 메디채널 김장윤(JASON KIM) 기자 ] Showcasing the full spectrum of American Whiskey and setting the high benchmark for Taipei's one-of-a-kind Outdoor Whiskey Festival TAIPEI, Dec. 11, 2025 -- The second annual Taiwan American Whiskey & Bourbon Festival successfully wrapped up on December 7 at Xinyi Xiangti Avenue in Taipei. Blessed with three days of clear weather, the event attracted over 1,800 whiskey enthusiasts, media, and international guests, transforming Taipei 101 precinct into a vibrant, celebrative, all-American carnival over the weekend. Organized by Joie de Viv
- 김장윤(JASON KIM) 기자
- 2025-12-11 15:32
CGS International Delivers Hallmark Year of IPOs, Strengthening its Role in Facilitating Capital Flows Across ASEAN Markets

Landmark year marked by successful listings across Singapore, Malaysia, and Thailand, spanning Singapore Exchange ("SGX") Mainboard, Catalist, Bursa Malaysia Main Market, and the Stock Exchange of Thailand ("SET"). Key milestones include Info-Tech Systems' Mainboard IPO, China Medical System's secondary listing, and Lum Chang Creations' Catalist debut in Singapore; UMS Integration's secondary listing, and Paradigm REIT's Main Market IPO in Malaysia; Mr D.I.Y. Thailand's listing on the SET. Out of 63 deals completed up to 11 December 2025, 14 were IPOs listed
- 황정호 기자
- 2025-12-11 14:45
Bowtie Announces New Headquarters - "Bowtie Life Insurance Tower"

HONG KONG, Dec. 11, 2025 -- Bowtie, Hong Kong's first virtual insurer[1], announces the strategic relocation of its headquarters to 68 Johnston Road, Wan Chai. Effective 1 February 2026, the building will be officially renamed "Bowtie Life Insurance Tower" ("Bowtie Tower"). Located in a prime and highly visible district, this milestone marks Bowtie's growth from a home-grown startup into Hong Kong's leading digital insurer, reaffirming its long-term commitment to the city. To support its continuous business growth, Bowtie has signed a five‑year lease spanning seven
- 황정호 기자
- 2025-12-11 14:26
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO

[ 메디채널 김갑성 기자 ] Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, including those who have relapsed or are refractory to checkpoint inhibitors, a multi-billion dollar pillar of cancer care, hampered by widespread resistance The study achieved its objective, as the new Q6W extended dosing interval produced encouraging anti-tumor efficacy and immunological data in prior immune-oncology refractory or relapsed patients including anti-PD- (L)1 checkpoint inhibitor, with improved safety, compared to the prior Q2W schedule Th
- 김갑성 기자
- 2025-12-11 14:12
OTR Therapeutics and Zealand Pharma enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases

[ 메디채널 김갑성 기자 ] Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral small-molecule platform and strong drug discovery capabilities, to discover and develop novel therapeutics for multiple targets in metabolic diseases OTR Therapeutics will receive an initial upfront payment of USD 20 million, which may increase to USD 30 million under certain pre-agreed conditions, and is eligible for potential preclinical, development, regulatory, and commercial milestone payments, for a potential total consideration of up to USD ~2
- 김갑성 기자
- 2025-12-11 14:00

이전

71 72 73 74 75 76 77 78 79 80

많이 본 기사

최근기사

2026-01-12_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 12일 13시 40분